Simplified strategies for minimal residual disease detection in B-cell precursor acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 95, Issue 2, 1996, Pages 281-290

  Landman Parker, J ^a   Aubin, J ^b,c   Delabesse, E ^d   Tabone, M D ^a   Adam, M ^a   Millien, C ^d   Leboeff, D ^b   Buzyn Veil, A ^b   Dollfus, C ^a   Leverger, G ^a   Macintyre, E A ^b,d  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c LAVAL UNIVERSITY   (Canada)

^d CNRS   (France)

Author keywords

Acute lymphoblastic leukaemia; Fingerprint; Fluorescence; IgH; PCR

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN H; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; B CELL LEUKEMIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA FINGERPRINTING; FLUORESCENCE; HUMAN; HUMAN CELL; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0006102229     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1917.x     Document Type: Article

References (32)

1. Aubin, J., Davi, F., Nguyen-Salomon, F., Leboeuf, D., Debert, C., Taher, M., Valensi, F., Canioni, D., Brousse, N., Varet, B., Flandrin, G. & Macintyre, E.A. (1995) Description of a novel FR1 IgH strategy and its comparison with three other strategies for the detection of clonality in B-cell malignancies. Leukemia. 9. 471-479.
2. Baruchel, A., Cayuela, J.M., Macintyre, E., Berger, R. & Sigaux, F. (1995) Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods: implication for a general strategy of minimal residual disease detection. British Journal of Haematology. 90, 85-93.
3. Beishuizen, A., Hahlen, K., Hagemeijer, A., Verhoeven, M.A., Hooijkaas, H., Adriaansen, H.J., Wolvers-Tettero, I.L., Van Wering, E.R. & Van Dongen, J.J. (1991) Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin. Leukemia. 5, 657-667.
4. Beishuizen, A., Verhoeven, M.-A.J., van Wering, E.R., Hählen, K., Hooijkaas, H. & van Dongen, J.J.M. (1994) Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent replase: implications for detection of minimal residual disease by polymerase chain reaction analysis. Blood. 83, 2238-2247.
5. Bennett, J.M. (1992) Detection of relapse in acute leukemia: should we discontinue routine bone marrow surveillance? Leukemia. 6, 1099-1100.
6. Bird, J., Galili, N., Link, M., Stites, D. & Sklar, J. (1988) Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukaemia. Journal of Experimental Medicine. 168, 229-245.
7. Brisco, M.J., Condon, J., Hughes, E., Neoh, S.H., Nicholson, I., Sykes, P.J., Tauro, G., Ekert, H., Waters, K., Toogood, I., Seshadri, R. & Morley, A.A. (1993) Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Australian and New Zealand Children's Cancer Study Group. Leukemia, 7, 1514-1520.
8. Brisco, M.J., Condon, J., Hughes, E., Neoh, S.H., Sykes, P.J., Seshadri, R., Toogood, I., Waters, K., Tauro, G., Ekert, H. & Morley, A.A. (1994) Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet. 343, 196-200.
9. Campana, D. & Pui, C.H. (1995) Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood. 85, 1416-1434.
10. Cavé, H., Bakkus, M., Suciu, S., Guidal, C., Fournier, M., Robert, A., Boutard, P., Mechinaud, F., Plouvier, E., Ferster, A., Nelken, B., Otten, J., Thielmans, K., Grandchamp, B. & Vilmer, E. (1995) Significance of the quantitation of minimal residual disease by PCR amplification of IgH and TCR gene rearrangements in childhood ALL: an EORTC prospective multicenter study. (Abstract). Blood. 86, 178a.
11. Chim, J.C.S., Coyle, L.A., Yaxley, J.C., Colesinclair, M.F., Cannell, P.K., Hoffbrand, V.A. & Foroni, L. (1996) The use of IgH fingerprinting and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL. British Journal of Haematology. 92, 104-115.
12. Deane, M., McCarthy, K.P., Wiedemann, L.M. & Norton, J.D. (1991) An improved method for detection of B-lymphoid clonality by polymerase chain reaction. British Journal of Haematology. 75, 726-730.
13. Deane, M. & Norton, J.D. (1991) Immunoglobulin gene 'fingerprinting': an approach to analysis of B lymphoid clonality in lymphoproliferative disorders. British Journal of Haematology. 77, 274-281.
14. Hansen-Hagge, T.E., Yokota, S. & Bartram, C.R. (1989) Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequences. Blood, 74, 1762-1767.
15. Kitchingman, G.R., Mirro, J., Stass, S., Rovigatti, U., Melvin, S.L., Williams, D.L., Raimondi, S.C. & Murphy, S.B. (1986) Biologic and prognostic significance of the presence of more than two mu heavy-chain genes in childhood acute lymphoblastic leukemia of B precursor cell origin. Blood, 67, 698-703.
16. Kneba, M., Bolz, I., Linke, B. & Hiddemann, W. (1995) Analysis of rearranged T-cell receptor beta-chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysis. Blood, 86, 3930-3937.
17. Lo Coco, F., Diverio, D., Pandolfi, P.P., Biondi, A., Rossi, V., Avvisati, G., Rambaldi, A., Arcese, W., Petti, M.C., Meloni, G., Mandelli, F., Grignani, F., Masera, G., Barbui, T. & Pelicci, P.G. (1992) Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia. Lancet, 340, 1437-1438.
18. + progenitors in bone marrow of BCL2-IgH positive follicular lymphoma patients. Blood, 86, 4691-4698.
19. Macintyre, E.A., d'Auriol, L., Duparc, N., Leverger, G., Galibert, F. & Sigaux, F. (1990) Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias. Journal of Clinical Investigation, 86, 2125-2135.
20. Nizet, Y., Van Daele, S., Lewalle, P., Vaerman, J.L., Philippe, M., Vermylen, C., Cornu, G., Ferrant, A., Michaux, J.L. & Martial, P. (1993) Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reaction. Blood. 82, 1618-1625.
21. Owen, R.G., Johnson, R.J., Evans, P.A., Smith, G.M., Child, J.A. & Morgan, G.J. (1995) Detection of clonal immunoglobulin gene rearrangements is the PBPC harvests of patients with acute lymphoblastic leukemia. Bone Marrow Transplantation, 16, 831-834.
22. Pannetier, C., Even, J. & Kourilsky, P. (1995) T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunology Today, 16, 176-181.
23. Potter, M. (1992) The detection of minimal residual disease in acute lymphoblastic leukemia. Blood Reviews, 6, 68-82.
24. Pui, C.-H. & Crist, W. (1994) Biology and treatment of acute lymphoblastic leukemia. Journal of Pediatrics. 124, 491.
25. Ravetch, J. V., Siebenlist, U., Korsmeyer, S., Waldmann, T. & Leder, P. (1981) Structure of the human immunoglobulin μ locus: characterization of embryonic and rearranged J and D genes. Cell, 27, 583-591.
26. Roberts, W., Estrov, Z., Kitchingman, G. & Zipf, T. (1996) The clinical significance of residual disease in childhood acute lymphoblastic leukaemia as detected by polymerase chain reaction amplification of antigen receptor gene sequences. Leukaemia and Lymphoma, 20, 181-197.
27. Romana, S.P., Poirel, H., Leconiat, M., Flexor, M.A., Mauchauffe, M., Jonveaux, P., Macintyre, E.A., Berger, R. & Bernard, O.A. (1995) High frequency of t(12: 21) in childhood B-lineage acute lymphoblastic leukemia. Blood, 86, 4263-4269.
28. Shiach, C., Evans, P., Short, M., Bailey, C., Lewis, I. & Kinsey, S. (1993) Detection and accurate sizing of PCR product by automated scanning: improved detection of immunoglobulin gene rearrangements in ALL. British Journal of Haematology. 85, 431-432.
29. Shurtleff, S.A., Buijs, A., Behm, F.G., Rubnitz, J.E., Raimondi, S.C., Hancock, M.L., Chan, G.C.F., Pui, C.H., Grosveld, G. & Downing, J.R. (1995) TEL/AML1 fusion resulting from a cryptic t(12:21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia. 9, 1985-1989.
30. Steenbergen, E.J., Verhagen, O.J.H.M., van Leeuwen, E.F., von dem Borne, A.E.G.K. & van der Schoot, C.E. (1993) Distinct ongoing Ig heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia. Blood, 82, 581-589.
31. Steward, C.G., Potter, M.N. & Oakhill, A. (1992) Third complementarity determining region (CDR-III) sequence analysis in childhood B-lineage acute lymphoblastic leukemia: implication for the design of oligonucleotide probes for use in monitoring minimal residual disease. Leukemia, 6, 1213-1219.
32. Wasserman, R., Galili, N., Ito, Y., Silber, J.H., Reichard, B.A., Shane, S., Womer, R.B., Lange, B. & Rovera, G. (1992) Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukaemia. Journal of Clinical Oncology, 10, 1879-1888.